OJSC "All-Russian Scientific Center for Molecular Diagnostics and Treatment"
Basic information
RCMDT is a modern research and production institute, specializing in the development of novel molecular methods of diagnosis and therapy. The production scale of the RCMDT Biotechnology Laboratory is about 50 panels of monoclonal antibodies (Mab) against a wide range of protein and non-protein antigens. The Laboratory has a profound background of “know-how”, making it possible to solve hard tasks of developing high affinity antibodies against dubious antigens: low molecular compounds, non-immunogenic and/or high toxicity proteins, peptides and other substances. We meet the challenge of developing the Mab with special properties, i.e. Mab with the neutralizing activity against viruses, enzymes, and cytokines. There is a positive experience of producing Mab, which work under the denaturing conditions. The all-round experience of the stuff is a good soil for the success of Mab production having minimal antigens amounts or without any at all.
Business type:
Location:
Moscow, RussiaProducts